621 related articles for article (PubMed ID: 16204028)
1. The threshold level of adenomatous polyposis coli protein for mouse intestinal tumorigenesis.
Li Q; Ishikawa TO; Oshima M; Taketo MM
Cancer Res; 2005 Oct; 65(19):8622-7. PubMed ID: 16204028
[TBL] [Abstract][Full Text] [Related]
2. APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression.
Janssen KP; Alberici P; Fsihi H; Gaspar C; Breukel C; Franken P; Rosty C; Abal M; El Marjou F; Smits R; Louvard D; Fodde R; Robine S
Gastroenterology; 2006 Oct; 131(4):1096-109. PubMed ID: 17030180
[TBL] [Abstract][Full Text] [Related]
3. Chromosomal instability by beta-catenin/TCF transcription in APC or beta-catenin mutant cells.
Aoki K; Aoki M; Sugai M; Harada N; Miyoshi H; Tsukamoto T; Mizoshita T; Tatematsu M; Seno H; Chiba T; Oshima M; Hsieh CL; Taketo MM
Oncogene; 2007 May; 26(24):3511-20. PubMed ID: 17160019
[TBL] [Abstract][Full Text] [Related]
4. Apc modulates embryonic stem-cell differentiation by controlling the dosage of beta-catenin signaling.
Kielman MF; Rindapää M; Gaspar C; van Poppel N; Breukel C; van Leeuwen S; Taketo MM; Roberts S; Smits R; Fodde R
Nat Genet; 2002 Dec; 32(4):594-605. PubMed ID: 12426568
[TBL] [Abstract][Full Text] [Related]
5. Morphological and molecular processes of polyp formation in Apc(delta716) knockout mice.
Oshima H; Oshima M; Kobayashi M; Tsutsumi M; Taketo MM
Cancer Res; 1997 May; 57(9):1644-9. PubMed ID: 9135000
[TBL] [Abstract][Full Text] [Related]
6. No effects of Smad2 (madh2) null mutation on malignant progression of intestinal polyps in Apc(delta716) knockout mice.
Takaku K; Wrana JL; Robertson EJ; Taketo MM
Cancer Res; 2002 Aug; 62(16):4558-61. PubMed ID: 12183405
[TBL] [Abstract][Full Text] [Related]
7. Haploinsufficiency of Krüppel-like factor 4 promotes adenomatous polyposis coli dependent intestinal tumorigenesis.
Ghaleb AM; McConnell BB; Nandan MO; Katz JP; Kaestner KH; Yang VW
Cancer Res; 2007 Aug; 67(15):7147-54. PubMed ID: 17671182
[TBL] [Abstract][Full Text] [Related]
8. Development of gastric tumors in Apc(Min/+) mice by the activation of the beta-catenin/Tcf signaling pathway.
Tomita H; Yamada Y; Oyama T; Hata K; Hirose Y; Hara A; Kunisada T; Sugiyama Y; Adachi Y; Linhart H; Mori H
Cancer Res; 2007 May; 67(9):4079-87. PubMed ID: 17483318
[TBL] [Abstract][Full Text] [Related]
9. RUNX3 attenuates beta-catenin/T cell factors in intestinal tumorigenesis.
Ito K; Lim AC; Salto-Tellez M; Motoda L; Osato M; Chuang LS; Lee CW; Voon DC; Koo JK; Wang H; Fukamachi H; Ito Y
Cancer Cell; 2008 Sep; 14(3):226-37. PubMed ID: 18772112
[TBL] [Abstract][Full Text] [Related]
10. Elevated Dnmt3a activity promotes polyposis in Apc(Min) mice by relaxing extracellular restraints on Wnt signaling.
Samuel MS; Suzuki H; Buchert M; Putoczki TL; Tebbutt NC; Lundgren-May T; Christou A; Inglese M; Toyota M; Heath JK; Ward RL; Waring PM; Ernst M
Gastroenterology; 2009 Sep; 137(3):902-13, 913.e1-11. PubMed ID: 19454286
[TBL] [Abstract][Full Text] [Related]
11. Genetic and epigenetic alterations of the APC gene in malignant melanoma.
Worm J; Christensen C; Grønbaek K; Tulchinsky E; Guldberg P
Oncogene; 2004 Jul; 23(30):5215-26. PubMed ID: 15133491
[TBL] [Abstract][Full Text] [Related]
12. Expression of adenomatous polyposis coli (APC) in tumorigenesis of human oral squamous cell carcinoma.
Tsuchiya R; Yamamoto G; Nagoshi Y; Aida T; Irie T; Tachikawa T
Oral Oncol; 2004 Oct; 40(9):932-40. PubMed ID: 15380172
[TBL] [Abstract][Full Text] [Related]
13. Intestinal polyposis in mice with a dominant stable mutation of the beta-catenin gene.
Harada N; Tamai Y; Ishikawa T; Sauer B; Takaku K; Oshima M; Taketo MM
EMBO J; 1999 Nov; 18(21):5931-42. PubMed ID: 10545105
[TBL] [Abstract][Full Text] [Related]
14. Myh deficiency enhances intestinal tumorigenesis in multiple intestinal neoplasia (ApcMin/+) mice.
Sieber OM; Howarth KM; Thirlwell C; Rowan A; Mandir N; Goodlad RA; Gilkar A; Spencer-Dene B; Stamp G; Johnson V; Silver A; Yang H; Miller JH; Ilyas M; Tomlinson IP
Cancer Res; 2004 Dec; 64(24):8876-81. PubMed ID: 15604247
[TBL] [Abstract][Full Text] [Related]
15. APC dosage effects in tumorigenesis and stem cell differentiation.
Gaspar C; Fodde R
Int J Dev Biol; 2004; 48(5-6):377-86. PubMed ID: 15349813
[TBL] [Abstract][Full Text] [Related]
16. Stat3 is a negative regulator of intestinal tumor progression in Apc(Min) mice.
Musteanu M; Blaas L; Mair M; Schlederer M; Bilban M; Tauber S; Esterbauer H; Mueller M; Casanova E; Kenner L; Poli V; Eferl R
Gastroenterology; 2010 Mar; 138(3):1003-11.e1-5. PubMed ID: 19962983
[TBL] [Abstract][Full Text] [Related]
17. Deletion of the WNT target and cancer stem cell marker CD44 in Apc(Min/+) mice attenuates intestinal tumorigenesis.
Zeilstra J; Joosten SP; Dokter M; Verwiel E; Spaargaren M; Pals ST
Cancer Res; 2008 May; 68(10):3655-61. PubMed ID: 18483247
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of intestinal polyposis with reduced angiogenesis in ApcMin/+ mice due to decreases in c-Myc expression.
Yekkala K; Baudino TA
Mol Cancer Res; 2007 Dec; 5(12):1296-303. PubMed ID: 18171987
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase 2- and prostaglandin E(2) receptor EP(2)-dependent angiogenesis in Apc(Delta716) mouse intestinal polyps.
Seno H; Oshima M; Ishikawa TO; Oshima H; Takaku K; Chiba T; Narumiya S; Taketo MM
Cancer Res; 2002 Jan; 62(2):506-11. PubMed ID: 11809702
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional profiling of the transition from normal intestinal epithelia to adenomas and carcinomas in the APCMin/+ mouse.
Paoni NF; Feldman MW; Gutierrez LS; Ploplis VA; Castellino FJ
Physiol Genomics; 2003 Nov; 15(3):228-35. PubMed ID: 13130079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
